Budesonide Capsule, Coated Pellets
Product Images NDC 16714-829
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 16714-829). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rx Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
07c3d402 Be9d 47f9 80f9 B2e3df738956 02
This is a medication with the NDC code 16714-829-01. It contains 3mg of budesonide, which is a delayed-release capsule for oral consumption. The manufacturer is listed as Gasla Healthcare, based in Ahmedabad, India, and the product is distributed by Northstar LLC of Memphis, TN. The recommended dosage is usually three capsules every morning, and it's important to keep it out of reach of children. The medication should be stored between 20°C and 25°C (68°F to 77°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.